|
US9850497B2
(en)
*
|
2013-11-04 |
2017-12-26 |
Regents Of The University Of Minnesota |
Gene targeting methods and tools
|
|
KR102415811B1
(ko)
|
2014-01-31 |
2022-07-04 |
팩터 바이오사이언스 인크. |
핵산 제조 및 송달을 위한 방법 및 산물
|
|
RU2756247C2
(ru)
|
2014-11-17 |
2021-09-28 |
Эдисет Био, Инк. |
Генетически модифицированные гамма дельта т-клетки
|
|
US11241505B2
(en)
|
2015-02-13 |
2022-02-08 |
Factor Bioscience Inc. |
Nucleic acid products and methods of administration thereof
|
|
CN104726495B
(zh)
*
|
2015-03-25 |
2018-06-19 |
西北农林科技大学 |
一种基于talen介导的基因打靶敲除山羊blg的载体及重组细胞
|
|
EP4600366A3
(en)
|
2015-03-31 |
2025-10-22 |
SOHM, Inc. |
Cas 9 retroviral integrase systems for targeted incorporation of a dna sequence into a genome of a cell
|
|
EP3292219B9
(en)
|
2015-05-04 |
2022-05-18 |
Ramot at Tel-Aviv University Ltd. |
Methods and kits for fragmenting dna
|
|
EP3770168A1
(en)
|
2015-05-18 |
2021-01-27 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
EP4339287A3
(en)
|
2015-07-31 |
2024-05-22 |
Regents Of The University Of Minnesota |
Modified cells and methods of therapy
|
|
WO2017075248A1
(en)
*
|
2015-10-27 |
2017-05-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of epidermolysis bullosa by injection of autologous collagen vii overexpressing leukocytes
|
|
ES2796488T3
(es)
*
|
2016-04-08 |
2020-11-27 |
Krystal Biotech Inc |
Composiciones para el uso en métodos para el tratamiento de heridas, trastornos y enfermedades de la piel
|
|
CN118421557A
(zh)
|
2016-05-12 |
2024-08-02 |
阿迪塞特治疗公司 |
选择性扩增γδT细胞群的方法及其组合物
|
|
WO2018026953A1
(en)
|
2016-08-02 |
2018-02-08 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
IL264439B2
(en)
|
2016-08-17 |
2024-08-01 |
Factor Bioscience Inc |
non-viral, cell-free composition comprising a synthetic messenger RNA (MRNA) encoding a gene-editing protein for use in treating cancer, and a synthetic RNA encoding a gene-editing protein for use in treatment
|
|
BR112019007100A2
(pt)
|
2016-10-07 |
2019-06-25 |
Tcr2 Therapeutics Inc |
composições e métodos para reprogramação de receptores de célula t com o uso de proteínas de fusão
|
|
EP4338799A3
(en)
|
2016-10-18 |
2024-06-05 |
Regents of the University of Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
|
CN110177803A
(zh)
|
2016-11-22 |
2019-08-27 |
T细胞受体治疗公司 |
用于使用融合蛋白进行tcr重新编程的组合物和方法
|
|
CA3047999A1
(en)
|
2016-12-21 |
2018-06-28 |
TCR2 Therapeutics Inc. |
Engineered t cells for the treatment of cancer
|
|
WO2018140497A1
(en)
|
2017-01-25 |
2018-08-02 |
Efimov Igor R |
Apparatus and methods for in vitro preclinical human trials
|
|
TW201839136A
(zh)
|
2017-02-06 |
2018-11-01 |
瑞士商諾華公司 |
治療血色素異常症之組合物及方法
|
|
WO2018154413A1
(en)
*
|
2017-02-22 |
2018-08-30 |
Crispr Therapeutics Ag |
Materials and methods for treatment of dystrophic epidermolysis bullosa (deb) and other collagen type vii alpha 1 chain (col7a1) gene related conditions or disorders
|
|
PL3638776T3
(pl)
|
2017-06-14 |
2026-02-23 |
Technische Universität Dresden |
Sposoby i środki do zmiany genetycznej genomów z wykorzystaniem projektowanych enzymów rekombinujących dna
|
|
JP7712643B2
(ja)
|
2017-06-19 |
2025-07-24 |
国立大学法人東北大学 |
表皮水疱症の治療剤
|
|
CN111511375A
(zh)
|
2017-06-30 |
2020-08-07 |
因提玛生物科学公司 |
用于基因治疗的腺相关病毒载体
|
|
CA3082818A1
(en)
|
2017-11-15 |
2019-05-23 |
Adicet Bio Inc. |
Methods for selective expansion of .delta.3 .gamma..delta. t-cell populations and compositions thereof
|
|
EP3775236A1
(en)
|
2018-04-12 |
2021-02-17 |
Krystal Biotech, LLC |
Compositions and methods for the treatment of autosomal recessive congenital ichthyosis
|
|
EP3781677A4
(en)
|
2018-04-16 |
2022-01-19 |
University of Massachusetts |
COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITTING
|
|
MX2020011257A
(es)
|
2018-04-27 |
2021-01-15 |
Krystal Biotech Inc |
Ácidos nucleicos recombinantes que codifican una o más proteínas cosméticas para usos estéticos.
|
|
WO2019217837A1
(en)
|
2018-05-11 |
2019-11-14 |
Memorial Sloan-Kettering Cancer Center |
T cell receptors targeting pik3ca mutations and uses thereof
|
|
EP3800998A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
|
EP3802839A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
|
EP3847243A1
(en)
*
|
2018-09-07 |
2021-07-14 |
Wisconsin Alumni Research Foundation |
Generation of hematopoietic progenitor cells from human pluripotent stem cells
|
|
AU2019346549B2
(en)
|
2018-09-24 |
2024-09-12 |
Krystal Biotech, Inc. |
Compositions and methods for the treatment of Netherton Syndrome
|
|
EP3856914A1
(en)
|
2018-09-26 |
2021-08-04 |
Krystal Biotech, Inc. |
Compositions and methods for the treatment of skin diseases
|
|
EP3887395A4
(en)
|
2018-11-30 |
2022-07-27 |
Intima Bioscience, Inc. |
METHODS FOR IDENTIFICATION OF IMMUNOMODULATORY GENES
|
|
CA3126896A1
(en)
|
2018-12-03 |
2020-06-11 |
Adicet Bio Inc. |
Methods for selective in vivo expansion of .gamma. .delta. t-cell populations and compositions thereof
|
|
CN113454105A
(zh)
|
2019-02-08 |
2021-09-28 |
克里斯托生物技术股份有限公司 |
用于递送cftr多肽的组合物和方法
|
|
MX2021012207A
(es)
|
2019-04-05 |
2021-12-10 |
Rootpath Genomics Inc |
Composiciones y métodos para ensamblaje de genes del receptor de linfocitos t.
|
|
US20220259617A1
(en)
|
2019-06-13 |
2022-08-18 |
The General Hospital Corporation |
Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
|
|
WO2020257684A1
(en)
|
2019-06-20 |
2020-12-24 |
University Of Massachusetts |
Compositions and methods for improved gene editing
|
|
CN114245745A
(zh)
|
2019-06-20 |
2022-03-25 |
纪念斯隆-凯特琳癌症中心 |
靶向pik3ca突变的t细胞受体及其用途
|
|
CA3145425A1
(en)
|
2019-07-03 |
2021-01-07 |
Factor Bioscience Inc. |
Cationic lipids and uses thereof
|
|
WO2021011936A2
(en)
|
2019-07-18 |
2021-01-21 |
University Of Rochester |
Cell-type selective immunoprotection of cells
|
|
US10501404B1
(en)
|
2019-07-30 |
2019-12-10 |
Factor Bioscience Inc. |
Cationic lipids and transfection methods
|
|
WO2021046243A2
(en)
|
2019-09-03 |
2021-03-11 |
Myeloid Therapeutics, Inc. |
Methods and compositions for genomic integration
|
|
US12091681B2
(en)
|
2020-03-27 |
2024-09-17 |
Mendus B.V. |
Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
|
|
WO2022003568A1
(en)
|
2020-06-30 |
2022-01-06 |
Dcprime B.V. |
Use of leukemia-derived cells in ovarian cancer vaccines
|
|
BR112023001272A2
(pt)
|
2020-07-24 |
2023-04-04 |
Massachusetts Gen Hospital |
Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células
|
|
IL301021A
(en)
|
2020-09-01 |
2023-05-01 |
64 X Inc |
Mammalian cells and methods for engineering the same
|
|
KR20230088833A
(ko)
|
2020-10-23 |
2023-06-20 |
루트패스 제노믹스, 인크. |
T-세포 수용체 식별을 위한 조성물 및 방법
|
|
WO2022155500A1
(en)
|
2021-01-14 |
2022-07-21 |
Senti Biosciences, Inc. |
Secretable payload regulation
|
|
KR20230135075A
(ko)
|
2021-01-22 |
2023-09-22 |
멘두스 비.브이. |
종양 백신접종 방법
|
|
WO2022190058A1
(en)
|
2021-03-12 |
2022-09-15 |
Dcprime B.V. |
Methods of vaccination and use of cd47 blockade
|
|
IL307350A
(en)
|
2021-04-02 |
2023-11-01 |
Krystal Biotech Inc |
Viral vectors for cancer treatment
|
|
WO2022241029A1
(en)
|
2021-05-11 |
2022-11-17 |
Myeloid Therapeutics, Inc. |
Methods and compositions for genomic integration
|
|
WO2023086847A1
(en)
|
2021-11-10 |
2023-05-19 |
Encodia, Inc. |
Methods for barcoding macromolecules in individual cells
|
|
CN119677842A
(zh)
|
2022-03-17 |
2025-03-21 |
科士华(南京)生物技术有限公司 |
人工合成肿瘤浸润淋巴细胞
|
|
EP4573114A4
(en)
|
2022-08-19 |
2026-07-29 |
Memorial Sloan Kettering Cancer Center |
T-LYMPHOCYTE RECEPTORS TARGETTING RAS MUTATIONS AND ASSOCIATED USES
|
|
WO2024105633A1
(en)
|
2022-11-18 |
2024-05-23 |
Kyoto Prefectural Public University Corporation |
Compositions for mitophagy induction and uses thereof
|
|
WO2025128981A1
(en)
|
2023-12-14 |
2025-06-19 |
Sohm, Inc. |
Compositions and methods for genome editing
|